← Back to Research← 返回研究
ELVEarnings ReleaseSource checkedJuly 15, 2026by InvestLog AI

ELV earnings release — EPS beat +20.6% · revenue beat +2.0% · gross margin 89.1% · operating margin 4.1%Elevance Health, Inc. (ELV) 财报发布 — EPS 高于预期+20.6% · 营收 高于预期+2.0% · 毛利率 89.1% · 经营利润率 4.1%

Earnings Release Event

Elevance Health Inc. (ELV) published results. Official release title: Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance; published at: 2026-07-15 06:00:00.

Actual vs Consensus

  • EPS: $7.45 vs $6.18 estimate, beat+20.6%.
  • Revenue: $49.8B vs $48.8B estimate, beat+2.0%.
  • Financial Quality Snapshot

  • Period: 2026 Q2 period ended 2026-06-30
  • Revenue: $50.5B; Revenue growth: +0.6%
  • Gross profit: $45.0B; Gross margin: 89.1%
  • Operating income: $2.1B; Operating margin: 4.1%
  • Net income: $1.5B; GAAP diluted EPS: $6.71
  • Operating cash flow: $1.9B; Capex: -$287M; Free cash flow: $1.6B; cash-flow status: available
  • Cash: $10.2B; Total debt: $31.0B; Net debt: $20.8B
  • 财报发布事件

    Elevance Health, Inc. (ELV) 已发布财报。官方发布标题:Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance;发布时间:2026-07-15 06:00:00。

    Actual vs Consensus

  • EPS:$7.45 vs $6.18 预期,高于预期+20.6%。
  • 营收:$49.8B vs $48.8B 预期,高于预期+2.0%。
  • 财务质量快照

  • 期间:2026 Q2 period ended 2026-06-30
  • 营收:$50.5B;营收增长:+0.6%
  • 毛利润:$45.0B;毛利率:89.1%
  • 经营利润:$2.1B;经营利润率:4.1%
  • 净利润:$1.5B;GAAP 稀释 EPS:$6.71
  • 经营现金流:$1.9B;资本开支:-$287M;自由现金流:$1.6B;现金流状态:available
  • 现金:$10.2B;总债务:$31.0B;净债务:$20.8B
  • This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考,不构成投资建议。